文献速递肝病

内质网应激诱导FOXA3促进非酒精性脂肪性肝病进展

FOXA3 induction under endoplasmic reticulum stress contributes to non-alcoholic fatty liver disease.
PubMed 文献 · J Hepatol · 2021-02-04

该研究通过腺病毒、siRNA和基因敲除小鼠模型,结合ChIP-seq和荧光素酶实验,发现内质网应激下XBP1s诱导FOXA3转录,FOXA3直接调控Per1进而促进Srebp1c等脂肪生成基因表达,加重肝脏脂质沉积和胰岛素抵抗;肥胖小鼠和NAFLD患者肝脏中FOXA3、PER1、SREBP1c水平升高,提示FOXA3是潜在治疗靶点。

要点

  • 内质网应激通过XBP1s诱导FOXA3转录。
  • FOXA3通过调控PER1/SREBP1c轴促进肝脏脂肪合成。
  • 抑制FOXA3可改善高脂饮食和db/db小鼠的脂肪肝表型。

核心结论

  • FOXA3是连接内质网应激与NAFLD进展的桥梁分子,XBP1s-FOXA3-PER1/Srebp1c转录轴参与NAFLD发生发展。

研究设计与样本

  • 研究使用腺病毒、siRNA和基因敲除小鼠构建FOXA3功能获得或缺失模型。
  • 采用衣霉素和高脂饮食分别诱导小鼠急性或慢性内质网应激。
  • 通过ChIP-seq、荧光素酶实验和腺病毒介导的下游基因操作揭示转录轴。
  • 对健康供者和NAFLD患者肝脏进行免疫组化染色评估关键轴蛋白水平。

主要发现

  • 内质网应激下XBP1s特异性诱导FOXA3转录。
  • FOXA3加重衣霉素诱导的急性内质网应激所致过度脂质积累,而肝细胞和小鼠中FOXA3缺失可减轻该积累。
  • 小鼠FOXA3缺失减少饮食诱导的慢性内质网应激、脂肪肝和胰岛素抵抗。
  • siRNA或腺相关病毒抑制FOXA3改善高脂饮食喂养和db/db小鼠的脂肪肝表型。
  • ChIP-seq显示FOXA3直接调控Period1(Per1)转录,进而促进Srebp1c等脂肪生成基因表达。

临床怎么用

  • FOXA3可作为脂肪肝疾病的潜在治疗靶点,未来或通过抑制FOXA3改善NAFLD。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Chronic endoplasmic reticulum (ER) stress in the liver has been shown to play a causative role in non-alcoholic fatty liver disease (NAFLD) progression, yet the underlying molecular mechanisms remain to be elucidated. Forkhead box A3 (FOXA3), a member of the FOX family, plays critical roles in metabolic homeostasis, although its possible functions in ER stress and fatty liver progression are unknown. METHODS: Adenoviral delivery, siRNA delivery, and genetic knockout mice were used to crease FOXA3 gain- or loss-of-function models. Tunicamycin (TM) and a high-fat diet (HFD) were used to induce acute or chronic ER stress in mice. Chromatin immunoprecipiation (ChIP)-seq, luciferase assay, and adenoviral-mediated downstream gene manipulations were performed to reveal the transcriptional axis involved. Key axis protein levels in livers from healthy donors and patients with NAFLD were assessed via immunohistochemical staining. RESULTS: FOXA3 transcription is specifically induced by XBP1s upon ER stress. FOXA3 exacerbates the excessive lipid accumulation caused by the acute ER-inducer TM, whereas FOXA3 deficiency in hepatocytes and mice alleviates it. Importantly, FOXA3 deficiency in mice reduced diet-induced chronic ER stress, fatty liver, and insulin resistance. In addition, FOXA3 suppression via siRNA or adeno-associated virus delivery ameliorated the fatty liver phenotype in HFD-fed and db/db mice. Mechanistically, ChIP-Seq analysis revealed that FOXA3 directly regulates Period1 (Per1) transcription, which in turn promotes the expression of lipogenic genes, including Srebp1c, thus enhancing lipid synthesis. Of pathophysiological significance, FOXA3, PER1, and SREBP1c levels were increased in livers of obese mice and patients with NAFLD. CONCLUSION: The present study identified FOXA3 as the bridging molecule that links ER stress and NAFLD progression. Our results highlighted the role of the XBP1s-FOXA3-PER1/Srebp1c transcriptional axis in the development of NAFLD and identified FOXA3 as a potential therapeutic target for fatty liver disease. LAY SUMMARY: The molecular mechanisms linking endoplasmic reticulum stress to non-alcoholic fatty liver disease (NAFLD) progression remain undefined. Herein, via in vitro and in vivo analysis, we identified Forkhead box A3 (FOXA3) as a key bridging molecule. Of pathophysiological significance, FOXA3 protein levels were increased in livers of obese mice and patients with NAFLD, indicating that FOXA3 could be a potential therapeutic target in fatty liver disease.

来源:J Hepatol,查看原文。版权归原作者所有。

引用

  1. Liu C, Zhou B, Meng M, et al. FOXA3 induction under endoplasmic reticulum stress contributes to non-alcoholic fatty liver disease. J Hepatol. 2021. PMID: 33548387. doi:10.1016/j.jhep.2021.01.042

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。